Search results
Scientists discover a gene for trust—here's how it could be linked to good health
Medical Xpress· 2 hours agoA recent breakthrough by our international team of researchers, published in Scientific Reports, has...
CDC issues update on H5N2 bird flu strain that killed Mexico man
Newsweek· 4 hours agoThe U.S. Centers for Disease Control and Prevention (CDC) has issued an update on the H5N2 bird flu...
How dodo de-extinction is helping rescue the extraordinary pink pigeon
New Scientist· 44 minutes agoWidely known for wanting to “de-extinct” the woolly mammoth, it said it was making strides in the ...
Mayo Clinic Study Reveals Startling Connection Between Energy Drinks and Sudden Cardiac Arrest
SciTechDaily· 14 hours agoA recent study published in Heart Rhythm, the official journal of the Heart Rhythm Society, the...
UK and Canada privacy watchdogs investigating 23andMe data breach
TechCrunch· 2 hours agoLast year, 23andMe disclosed a security incident that affected the genetic and ancestry data of 6.9...
QIAGEN (QGEN) Unveils dPCR Tool, Enhances GeneGlobe Platform
Zacks via Yahoo Finance· 4 hours agoThis is also likely to boost QIAGEN’s Life Science business area. Significance of the New dPCR...
Study Identifies Genetic Variant as a Clear Cause of Alzheimer's—Does This Mean You Should Get...
Health via Yahoo News· 5 days agoNew research suggests that having two copies of a gene variant could be an underlying cause—not just...
Is there genetic testing for Alzheimer’s disease?
St. Louis Post-Dispatch· 4 days agoLee Enterprises newsroom and editorial were not involved in the creation of this content. If someone in your family has ever suffered from Alzheimer’s,...
Philadelphia nonprofit using "cool cars" to raise money for children with genetic disorders
CBS News· 3 days agoIt is estimated that one in every 25 children is affected by a rare genetic disorder —many of which...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 hours agoBridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced ...